Intrinsic pontine tumors: Pathology of brainstem tumors and exploration of diffuse intrinsic pontine glioma.
1/5 보강
Over the past decade, advances in brainstem biopsies and the discovery of the histone H3 mutation have revealed a new spectrum of brainstem tumors.
APA
Moon R, Mueller S, Varlet P (2026). Intrinsic pontine tumors: Pathology of brainstem tumors and exploration of diffuse intrinsic pontine glioma.. Handbook of clinical neurology, 216, 171-182. https://doi.org/10.1016/B978-0-443-15736-3.00020-2
MLA
Moon R, et al.. "Intrinsic pontine tumors: Pathology of brainstem tumors and exploration of diffuse intrinsic pontine glioma.." Handbook of clinical neurology, vol. 216, 2026, pp. 171-182.
PMID
41896005 ↗
Abstract 한글 요약
Over the past decade, advances in brainstem biopsies and the discovery of the histone H3 mutation have revealed a new spectrum of brainstem tumors. In the brainstem, diffuse midline gliomas (DMGs) are most common in the pediatric population, followed by less aggressive tumors like pilocytic astrocytomas. The 2016 WHO central nervous system (CNS) classification introduced diagnostic criteria for DMGs, which have since evolved into five subtypes. These new subtypes present challenges for histomolecular diagnosis in biopsies. Recent data suggest these subtypes differ in clinical outcomes and prognosis, and most likely will require different therapies highlighting the need for tissue for diagnostic purposes for brainstem lesions. This chapter will first cover an overview of different brainstem pathologies, followed by a discussion on imaging, treatment standards, and the evolving role of biopsies in DMG including diffuse intrinsic pontine gliomas.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.